These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8903958)

  • 1. Synthesis, receptor binding, and crosslinking of photoactive analogues of neuropeptide Y.
    Beck-Sickinger AG; Wieland HA; Brunner J
    J Recept Signal Transduct Res; 1995; 15(1-4):473-85. PubMed ID: 8903958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescent labelled analogues of neuropeptide Y for the characterization of cells expressing NPY receptor subtypes.
    Ingenhoven N; Beck-Sickinger AG
    J Recept Signal Transduct Res; 1997; 17(1-3):407-18. PubMed ID: 9029504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of the human neuropeptide Y Y2-receptor.
    Ingenhoven N; Eckard CP; Gehlert DR; Beck-Sickinger AG
    Biochemistry; 1999 May; 38(21):6897-902. PubMed ID: 10346911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative structural requirements of brain neuropeptide Y binding sites and vas deferens neuropeptide Y receptors.
    Martel JC; Fournier A; St-Pierre S; Dumont Y; Forest M; Quirion R
    Mol Pharmacol; 1990 Oct; 38(4):494-502. PubMed ID: 2172766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression cloning of a human brain neuropeptide Y Y2 receptor.
    Gehlert DR; Beavers LS; Johnson D; Gackenheimer SL; Schober DA; Gadski RA
    Mol Pharmacol; 1996 Feb; 49(2):224-8. PubMed ID: 8632753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of neuropeptide Y analogues with respect to Y1 and Y2 receptors.
    Beck-Sickinger AG; Jung G
    Biopolymers; 1995; 37(2):123-42. PubMed ID: 7893945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5.
    Berglund MM; Saar K; Lundell I; Langel U; Larhammar D
    Neuropeptides; 2001; 35(3-4):148-53. PubMed ID: 11884204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonistic properties of centrally truncated analogs of [D-Trp(32)]NPY.
    Balasubramaniam A; Ujhelyi M; Borchers M; Huang Y; Zhai W; Zhou Y; Johnson M; Sheriff S; Fischer JE
    J Med Chem; 1996 Mar; 39(5):1142-7. PubMed ID: 8676351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rational approach for the development of reduced-size analogues of neuropeptide Y with high affinity to the Y1 receptor.
    Rist B; Wieland HA; Willim KD; Beck-Sickinger AG
    J Pept Sci; 1995; 1(5):341-8. PubMed ID: 9223013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete L-alanine scan of neuropeptide Y reveals ligands binding to Y1 and Y2 receptors with distinguished conformations.
    Beck-Sickinger AG; Wieland HA; Wittneben H; Willim KD; Rudolf K; Jung G
    Eur J Biochem; 1994 Nov; 225(3):947-58. PubMed ID: 7957231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
    Gehlert DR; Schober DA; Beavers L; Gadski R; Hoffman JA; Smiley DL; Chance RE; Lundell I; Larhammar D
    Mol Pharmacol; 1996 Jul; 50(1):112-8. PubMed ID: 8700103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid-phase synthesis of caged peptides using tyrosine modified with a photocleavable protecting group: application to the synthesis of caged neuropeptide Y.
    Tatsu Y; Shigeri Y; Sogabe S; Yumoto N; Yoshikawa S
    Biochem Biophys Res Commun; 1996 Oct; 227(3):688-93. PubMed ID: 8885995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
    Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
    Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stabilization of alpha-helix in C-terminal fragments of neuropeptide Y.
    Yumoto N; Murase S; Hattori T; Yamamoto H; Tatsu Y; Yoshikawa S
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1490-5. PubMed ID: 8250906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel modified and radiolabelled neuropeptide Y analogues to study Y-receptor subtypes.
    Koglin N; Beck-Sickinger AG
    Neuropeptides; 2004 Aug; 38(4):153-61. PubMed ID: 15337368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor.
    Krause J; Eva C; Seeburg PH; Sprengel R
    Mol Pharmacol; 1992 May; 41(5):817-21. PubMed ID: 1316999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor.
    Sautel M; Rudolf K; Wittneben H; Herzog H; Martinez R; Munoz M; Eberlein W; Engel W; Walker P; Beck-Sickinger AG
    Mol Pharmacol; 1996 Aug; 50(2):285-92. PubMed ID: 8700135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226.
    Wieland HA; Willim KD; Entzeroth M; Wienen W; Rudolf K; Eberlein W; Engel W; Doods HN
    J Pharmacol Exp Ther; 1995 Oct; 275(1):143-9. PubMed ID: 7562543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strongly altered receptor binding properties in PP and NPY chimeras are accompanied by changes in structure and membrane binding.
    Lerch M; Kamimori H; Folkers G; Aguilar MI; Beck-Sickinger AG; Zerbe O
    Biochemistry; 2005 Jun; 44(25):9255-64. PubMed ID: 15966750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of covalent dimerization on the structure and function of the carboxy-terminal fragment of neuropeptide Y.
    Uegaki K; Murase S; Nemoto N; Kobayashi Y; Yoshikawa S; Yumoto N
    Biochem Biophys Res Commun; 1997 Dec; 241(3):737-43. PubMed ID: 9434778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.